Page last updated: 2024-10-21

5-hydroxydecanoate and Anochlesia

5-hydroxydecanoate has been researched along with Anochlesia in 1 studies

5-hydroxydecanoic acid: Potassium Channel Blocker; RN refers to parent cpd

Research Excerpts

ExcerptRelevanceReference
" Studies also found that iptakalim and diazoxide could reduce the enzymic activities and mRNA levels of inducible nitric oxide synthase elicited by chronic administration of rotenone."1.33Activation of mitochondrial ATP-sensitive potassium channels improves rotenone-related motor and neurochemical alterations in rats. ( Ding, JH; Hu, G; Liu, SY; Liu, X; Long, Y; Sun, YH; Wang, F; Wang, H; Wu, J; Yang, Y; Yao, HH, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yang, Y1
Liu, X1
Long, Y1
Wang, F1
Ding, JH1
Liu, SY1
Sun, YH1
Yao, HH1
Wang, H1
Wu, J1
Hu, G1

Other Studies

1 other study available for 5-hydroxydecanoate and Anochlesia

ArticleYear
Activation of mitochondrial ATP-sensitive potassium channels improves rotenone-related motor and neurochemical alterations in rats.
    The international journal of neuropsychopharmacology, 2006, Volume: 9, Issue:1

    Topics: Animals; Antiparkinson Agents; Basal Ganglia; Catalepsy; Decanoic Acids; Diazoxide; Disease Models,

2006